Armando Andres Roca Suarez

Virologist seeking to understand the complexities of liver disease by day and of brazilian jiu-jitsu by night. @IHU_HepatoLyon @ipcureb

[Armando Andres Roca Suarez @andresroca]

Big thanks to the members of the @IHU_HepatoLyon, @ipcureb and @Gut_BMJ for the opportunity to share our work. @TestoniResearch @FabienZoulim @MPlissonnier
#HBV #Kupffer #livertwitter #liverx
https://t.co/B8791sA14R

[bioRxiv Microbiology @biorxiv_micrbio]

Precision-cut liver slices as a model for the evaluation of host-targeting agents against hepatitis B and delta viruses https://t.co/wWeF3gVoho #biorxiv_micrbio

[Armando Andres Roca Suarez @andresroca]

We look forward to receiving your contributions to the special issue "Cellular Immune Response to Hepatitis Viruses".
Deadline : 31 January 2026
#livertwitter
https://t.co/6npc1DEnO9

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

Ahead of #WorldHepatitisDay on July 28th, we've published a collection of viral hepatitis-related content...

Follow the🧵below!

#LiverTwitter #IDTwitter #MedTwitter #nohep

[nature @Nature]

Researchers with ADHD discuss its peaks and valleys and how they structure their work lives to succeed

https://t.co/M7RbTbvlFX

[Daniel J Drucker @DanielJDrucker]

Studies with Tocilzumab in humans reveal that post-meal, IL-6 activity promotes the storage of meal-derived fatty acids in subcutaneous fat and increases the escape of meal-derived fatty acids into the bloodstream https://t.co/CBj9Z3H5KM @CellRepMed

[eGastroenterology @eGastro_BMJ]

📢 New Research Alert! 🚀
🏥Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
🔬 New findings reveal that hepatic PTPRD expression is associated with signaling pathways regulating glucose and lipid metabolism, highlighting its key role in metabolic liver disease. #LiverDisease #Metabolism #STAT3 #Hepatology #MedicalResearch
📖 Read more: https://t.co/YBbq3AwKbI
@Gut_BMJ @BMJ_Open @FrontGastro_BMJ

[eGastroenterology @eGastro_BMJ]

💡Don't miss this perspective in eGastroenterology!💡The perspective, “New dimension in viral hepatitis research” by Massimiliano Cocca and Barbara Testoni from the INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, interprets a proof-of-concept study demonstrates the feasibility of spatial transcriptomics in analysing HBV infections.🔍📖#HepatitisB #SpatialTranscriptomics #HBV #LiverResearch
🔗https://t.co/9qHKHNSsNo
@Gut_BMJ @BMJ_Open @FrontGastro_BMJ

[Nicolaas Van Renne @NVanRenne]

🚨 New paper out! 🚨

We show how hepatitis B virus (HBV) mRNA can be detected in single-cell RNA sequencing without prior knowledge or specific amplification.

📄 Read here: https://t.co/PWsjGXJGvH

🔬 Code: https://t.co/V6aTtFbz5c

#HBV #scRNAseq #Virology #Bioinformatics

[Rui Castro @RuiCastroHD]

Extrahepatic complications of MASLD: cause or association? It depends on:

👉🏼 Genetic background
👉🏼 MASLD severity - increasing insulin resistance & risk of T2DM
👉🏼 Other cardiometabolic risk factors

#SLDsummit state-of-the-art by Cyrielle Caussy @IHU_HepatoLyon

@EASLnews

[Eric Topol @EricTopol]

Spatial multi-omics has just gone to the next level!
https://t.co/joA2nhNgqE
https://t.co/ZTIt1gAu5l
—Integration of 5 omic modalities w/ spatial resolution at 20 -50 μm
—"a new era for characterizing tissue & cellular heterogeneity that single-modality studies alone could not reveal"

[Nature Biotechnology @NatureBiotech]

Making space for spatial biology in the clinic
Spatial transcriptomics methods have been slow to move into clinical practice, but spatial proteomics are cheaper and more scalable, and could progress faster https://t.co/0ff7OMxexN

[The Roger Williams Institute of Liver Studies @Inst_of_Liver]

📢📢 POST-DOC JOB VACANCY 📢📢

We're currently hiring for a Post-Doctoral Scientist to join our Liver-Brain Axis group 🧠 working on "Understanding the Mechanisms underlying the Detrimental Effects of MASLD on the Brain" 👩‍🔬🧫

Follow the link below for more info and to apply today!

https://t.co/ZRZ4mrpHC9

#ScienceCareers #STEMcareers #PostDoc #PostDoctoral #LiverTwitter #LiverResearch #Hepatology #LiverBrainAxis

@AHadjihambi @phil_newsome7 @f4liverresearch @kingsmedicine @KCLImmunoMicro @KingsCollegeNHS @KingsCollegeLon

[Journal of Hepatology @JHepatology]

🆕Article in press❕

Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta

Read it here👉https://t.co/ojLNcqEQlX

#LiverTwitter

[Journal of Hepatology @JHepatology]

📌In our December issue

Hepatitis B virus DNA integration
➡️Implications for diagnostics, therapy, and outcome

#OpenAccess here👉https://t.co/sGhVisafY5

@FabienZoulim
#LiverTwitter

[Gut Journal @Gut_BMJ]

Watch the latest #GUTVideo from the paper by Roca Suarez @andresroca et al entitled

"TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism" via

https://t.co/7gJeGSNcSf

Paper via: https://t.co/CX4Lra7cc2

@ipcureb @IHU_HepatoLyon @TestoniResearch @FabienZoulim @MPlissonnier #HBV

[IHU Hepatologie Lyon @IHU_HepatoLyon]

📣The IHU Everest is leaving the X social media platform.
You can now follow our news on #Bluesky 👉https://t.co/ZnTd10a9zv

[nature @Nature]

Fructose aids tumour growth, but cancer cells usually lack the enzymes needed to metabolize this sugar https://t.co/ebHSFTzqSx

[Gut Journal @Gut_BMJ]

Watch the latest #GUTVideo from the paper by Roca Suarez @andresroca et al entitled

"TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism" via

https://t.co/7gJeGSNcSf

Paper via: https://t.co/CX4Lra7cc2

@ipcureb @IHU_HepatoLyon @TestoniResearch @FabienZoulim @MPlissonnier #HBV

[NEJM @NEJM]

Drs. Harry L.A. Janssen and Milan J. Sonneveld describe the science behind a clinical trial of a combination of therapies, including xalnesiran, to treat chronic hepatitis B virus infection. Read the full editorial: https://t.co/5MvQYbJmtT